MDSpire - Takeaway
Feature

Machine Learning Enables Real-Time Bioprocess Optimization

An integrated machine learning framework adapts culture conditions during long perfusion runs

  • March 23, 2026

  • 2 min

Share

  • 1

    Self-driving bioprocessing platform developed by Merck.

  • 2

    Integrates machine learning with bioreactors.

  • 3

    Enables real-time adaptation of experiments.

  • 4

    Autonomously operated for 20 days during proof of concept.

  • 5

    Focuses on monoclonal antibody optimization.

  • 6

    Reduces reliance on manual inputs.

  • 7

    Enhances production efficiency and shortens development timelines.

Original Source(s)

Machine Learning Enables Real-Time Bioprocess Optimization

  • March 23, 2026

Related Content

Hand Photos May Flag Rare Hormone Disorder

Deep learning model identifies disease using dorsal hand images

  • March 23, 2026

  • 3 min
The Lipitor Warning for GLP-1 Drugmakers

Pfizer’s Lipitor experience shows the structural risks that today’s GLP-1 innovators may soon face

Obesity Care Lags Behind Advances in Treatment

A 2026 expert perspective highlights system-level gaps in care delivery